{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["11(1)"],"submitter":["Palandri F"],"journal":["Blood cancer journal"],"pagination":["4"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7791065"],"repository":["biostudies-literature"],"pubmed_title":["Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis."],"pmcid":["PMC7791065"],"pubmed_authors":["Pugliese N","Cuneo A","Heidel F","Bonifacio M","Crugnola M","Cavo M","Trawinska MM","Benevolo G","Martino B","Isidori A","Iurlo A","Breccia M","Latagliata R","Scaffidi L","Palandri F","Ciantia F","Bosi C","Lemoli RM","Stella R","Binotto G","Tieghi A","Pane F","Abruzzese E","Bartoletti D","Polverelli N","Caocci G","Vianelli N","Palumbo GA","Semenzato G","Cavazzini F","Bergamaschi M","Tiribelli M","Cattaneo D","Krampera M","Elli EM","Auteri G"],"additional_accession":[]},"is_claimable":false,"name":"Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis.","description":null,"dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Jan","modification":"2025-04-25T20:39:45.776Z","creation":"2025-04-06T08:26:16.424Z"},"accession":"S-EPMC7791065","cross_references":{"pubmed":["33414394"],"doi":["10.1038/s41408-020-00392-1"]}}